Table 5 Summary of interventions in the management of MOH by cause^a

 Oxytocin^d

13

10

7

35

24

98

82.4

 Ergometrine

7

1

3

1

9

23

19.3

 Misoprostol

5

3

–

3

7

20

16.8

 Tranexamic acid

2

1

2

4

8

18

15.1

 Prostaglandin F2-alpha

3

–

1

1

3

8

6.7

 Balloon or condom

 tamponade

6

–

–

1

1

10

8.4

 Relook laparotomy

5

–

2

2

24

34

28.6

 Hysterectomy

6

2

7

1

14

33

27.7

 Removal of retained products

3

10

2

4

3

23

19.3

 Tear repair in theatre

–

2

–

6

2

16

13.4

 B-Lynch suture

5

–

1

3

4

13

10.9

 Abdominal packing

2

–

–

1

1

4

3.4

 Artery ligation

–

–

–

1

2

3

2.5

 Uterine rupture repair

–

–

–

–

–

1

0.8

 Uterine inversion reversal

–

–

–

–

–

1

0.8

 Transfusion of blood products

13

10

10

45

29

117

98.3

 Massive transfusion

1

1

2

5

9

20

16.8

 Admission to ICU

2

–

1

1

6

11

9.2

 Missing data

3

2.5